(Q37990967)

26 August 2017

title

Recent advances in metabolomics in oncology (English)

1 reference

26 August 2017

1 reference

Thomas M O'Connell

1 reference

26 August 2017

publication date

1 February 2012

1 reference

26 August 2017

1 reference

26 August 2017

1 reference

26 August 2017

1 reference

26 August 2017

page(s)

431-451

1 reference

Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Functional genomics: lessons from yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Hereditary breast cancer: pathobiology, clinical translation, and potential for targeted cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Genetic alterations in sporadic and hereditary colorectal cancer: implementations for screening and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Current Strategies in The Discovery of Small-Molecule Biomarkers for Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Metabonomics: a platform for studying drug toxicity and gene function

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

The comparison of plasma deproteinization methods for the detection of low-molecular-weight metabolites by (1)H nuclear magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Improved identification of metabolites in complex mixtures using HSQC NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Microflow NMR: concepts and capabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

The expanding role of mass spectrometry in metabolite profiling and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Stable isotope dilution assays in mycotoxin analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Mass spectrometry-based metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Gas chromatography/mass spectrometry in metabolic profiling of biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Chemometrics in metabolomics--a review in human disease diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

To aggregate or not to aggregate high-dimensional classifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Enhancement of plant metabolite fingerprinting by machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Hypoxia signalling controls metabolic demand

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Tumor cell metabolism: cancer's Achilles' heel

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Regulation of tumor pH and the role of carbonic anhydrase 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Why do cancers have high aerobic glycolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Molecular concepts analysis links tumors, pathways, mechanisms, and drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Integrative molecular concept modeling of prostate cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Efforts to resolve the contradictions in early diagnosis of prostate cancer: a comparison of different algorithms of sarcosine in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Early detection of second breast cancers improves prognosis in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Studies of human tumors by MRS: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Early Detection of Recurrent Breast Cancer Using Metabolite Profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: Application to the detection of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Multivariate classification of urine metabolome profiles for breast cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Discovery of meaningful associations in genomic data using partial correlation coefficients

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Genetic predisposition to colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Prevention of colorectal cancer: diet, chemoprevention, and lifestyle

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Urinary metabonomic study on colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Species variation in the fecal metabolome gives insight into differential gastrointestinal function

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

(1)H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Metabolite profiling of fecal water extracts from human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Fiber-derived butyrate and the prevention of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Role of butyric acid and its derivatives in the treatment of colorectal cancer and hemoglobinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Changing international trends in mortality rates for liver, biliary and pancreatic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Hepatocellular carcinoma: recent trends in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Hepatocellular carcinoma cases with five-year survival and prognostic factors affecting the survival time

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Management of liver disease in Nigeria.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Merging transcriptomics and metabolomics--advances in breast cancer profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Study on metabonomic characteristics of human lung cancer using high resolution magic‐angle spinning 1H NMR spectroscopy and multivariate data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Urinary metabonomic study of lung cancer by a fully automatic hyphenated hydrophilic interaction/RPLC-MS system

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Ovarian cancer detection from metabolomic liquid chromatography/mass spectrometry data by support vector machines.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Rapid mass spectrometric metabolic profiling of blood sera detects ovarian cancer with high accuracy.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Diagnosis of Early Stage Ovarian Cancer by1H NMR Metabonomics of Serum Explored by Use of a Microflow NMR Probe

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Urine metabolomics analysis for kidney cancer detection and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Pathway analysis of kidney cancer using proteomics and metabolic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Noninvasive urinary metabonomic diagnosis of human bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Chronic myeloid leukemia patients sensitive and resistant to imatinib treatment show different metabolic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Assessment of Analytical Reproducibility of1H NMR Spectroscopy Based Metabonomics for Large-Scale Epidemiological Research: the INTERMAP Study

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Blood Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Urine

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.11.326

21 January 2018

Identifiers

DOI

10.4155/BIO.11.326

1 reference

26 August 2017

1 reference